Blumea fastulosa (Roxb.) Kurz.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | B. glomerata DC. |
| Family | Compositae; Asteraceae. |
| Habitat | Tropical Himalayas, and throughout the plains of Assam and Penninsular India. |
| Ayurvedic | Kukundara (var.). |
| Unani | Kakarondaa. |
| Action | Plant—diuretic. Essential oil—CNS depressant. |
| Taxonomic Cohort | Genus Blumea (5 documented species); Family Compositae (91 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Blumea fastulosa (taxonomically cited with authority (Roxb.) Kurz.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Compositae; Asteraceae (primary family classification: Compositae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy B. glomerata DC, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Tropical Himalayas, and throughout the plains of Assam and Penninsular India.
Across classical and vernacular Indian systems of medicine, Blumea fastulosa is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Kukundara (var.); in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Kakarondaa. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Blumea fastulosa are: Plant—diuretic. Essential oil—CNS depressant. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Blumea fastulosa establish the following evidence base: The steam non-volatile fraction of plant extract contained a mixture of n-alkanes.
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Blumea comprises 5 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Blumea balsamifera (Action: Tranquilizer (used in excitement and insomnia), expectorant, sudorific. Given in…); Blumea densiflora (Action: Juice of fresh leaves— insecticidal, mosquito repellant. The plant yields an…); Blumea eriantha (Action: Juice of the herb— carminative. A warm infusion of leaves is given as a…); Blumea lacera. (Action: Plant—antipyretic. Leaf— astringent, febrifuge, diuretic, deobstruent…). Comparing Blumea fastulosa alongside its congeners in genus Blumea highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Compositae encompasses 91 documented medicinal species (5.02% of the 1,814-species flora). Other representative medicinal members of Compositae include: Acanthospermum hispidum (Trikantaka), Achillea millefolium (Milfoil), Ainsliaea aptera (Karui Buuti), Amberboa divaricata (Brahmadandi), Anacyclus pyrethrum (Aakaarakarabha). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 91 medicinal species of family Compositae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Blumea fastulosa follow the plant-part modalities specified under its therapeutic action (Plant—diuretic. Essential oil—CNS depressant), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Blumea fastulosa integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.